Refractory status epilepticus responding to lidocaine: A case report

Show simple item record

dc.contributor.author Özer, Gökhan
dc.date.accessioned 2021-11-11T07:21:16Z
dc.date.available 2021-11-11T07:21:16Z
dc.date.issued 2018
dc.identifier.issn 2149-3189
dc.identifier.uri http://openaccess.sanko.edu.tr/xmlui/handle/20.500.12527/589
dc.description.abstract Status epilepticus is a life-threatening condition, which is associated with a high mortality and morbidity when left untreated. It is defined as a continuous seizure lasting more than 30 min or successive seizures with no recovery between any of them. Mortality of status epilepticus depends on the duration and type of seizure, concomitant diseases and age of the patient. Management of status epilepticus includes ensuring adequate airway, stabilization of circulation and use of antiepileptic drugs. Benzodiazepines, phenobarbital, phenytoin, fosphenytoin, general anesthesia and lidocaine are used for the treatment of status epilepticus. Here, we discuss a patient with refractory status epilepticus who achieved a very good response and full recovery only with lidocaine infusion among all forms of therapy given. en_US
dc.language.iso German en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title Refractory status epilepticus responding to lidocaine: A case report en_US
dc.type Article en_US
dc.relation.journal The European Research Journal en_US
dc.identifier.issue 3 en_US
dc.identifier.startpage 254 en_US
dc.identifier.endpage 257 en_US
dc.identifier.volume 4 en_US
dc.contributor.authorID 0000-0003-0039-2350 : Gökhan Özer en_US
dc.identifier.doi https://doi.org/10.18621/eurj.361883 en_US
dc.contributor.sankoauthor Gökhan Özer en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Gazimuhtar Paşa Bulvarı
No:36
27090
Şehitkamil / GAZİANTEP